PMC:7128678 / 3147-3293 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"87","span":{"begin":87,"end":118},"obj":"Gene"},{"id":"88","span":{"begin":120,"end":125},"obj":"Gene"}],"attributes":[{"id":"A87","pred":"tao:has_database_id","subj":"87","obj":"Gene:59272"},{"id":"A88","pred":"tao:has_database_id","subj":"88","obj":"Gene:59272"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":",5]. Interestingly, CLQ has been shown to interfere with the terminal glycosylation of angiotensin-converting enzyme-2 (ACE-2) [7], which acts as "}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T73","span":{"begin":87,"end":118},"obj":"PG_10;PR:000003622"},{"id":"T74","span":{"begin":120,"end":125},"obj":"G_3;PG_10;PR:000003622"}],"text":",5]. Interestingly, CLQ has been shown to interfere with the terminal glycosylation of angiotensin-converting enzyme-2 (ACE-2) [7], which acts as "}

{"project":"LitCovid_AGAC","denotations":[{"id":"p88102s10","span":{"begin":61,"end":83},"obj":"MPA"}],"text":",5]. Interestingly, CLQ has been shown to interfere with the terminal glycosylation of angiotensin-converting enzyme-2 (ACE-2) [7], which acts as "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T17","span":{"begin":24,"end":27},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":",5]. Interestingly, CLQ has been shown to interfere with the terminal glycosylation of angiotensin-converting enzyme-2 (ACE-2) [7], which acts as "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T37","span":{"begin":87,"end":98},"obj":"Chemical"}],"attributes":[{"id":"A37","pred":"chebi_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/CHEBI_48433"}],"text":",5]. Interestingly, CLQ has been shown to interfere with the terminal glycosylation of angiotensin-converting enzyme-2 (ACE-2) [7], which acts as "}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T3","span":{"begin":61,"end":83},"obj":"http://purl.obolibrary.org/obo/GO_0033578"},{"id":"T4","span":{"begin":70,"end":83},"obj":"http://purl.obolibrary.org/obo/GO_0070085"}],"text":",5]. Interestingly, CLQ has been shown to interfere with the terminal glycosylation of angiotensin-converting enzyme-2 (ACE-2) [7], which acts as "}

{"project":"2_test","denotations":[{"id":"32251731-16439323-48149936","span":{"begin":1,"end":2},"obj":"16439323"},{"id":"32251731-16115318-48149937","span":{"begin":128,"end":129},"obj":"16115318"},{"id":"T11075","span":{"begin":1,"end":2},"obj":"16439323"},{"id":"T4317","span":{"begin":128,"end":129},"obj":"16115318"}],"text":",5]. Interestingly, CLQ has been shown to interfere with the terminal glycosylation of angiotensin-converting enzyme-2 (ACE-2) [7], which acts as "}